Global Insulin Sensitizers Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Insulin Sensitizers Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Insulin sensitizer, also known as "insulin sensitizer", is a kind of peroxisome proliferator-activated receptor (PPAR) agonist, a special substance that enhances insulin sensitivity in the human body and promotes the full utilization of insulin.
Insulin Sensitizers report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Insulin Sensitizers market is projected to reach US$ 20930 million in 2029, increasing from US$ 14290 million in 2022, with the CAGR of 5.6% during the period of 2024 to 2029. Demand from Hospital and Drugstore are the major drivers for the industry.
According to the Global Use of Medicines 2024 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Insulin Sensitizers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Sanofi
Novo Nordisk
Lilly
MSD
Boehringer Ingelheim
Chipscreen Biosciences
Shandong Lukang Pharmaceutical
Zhejiang Hisun Pharmaceutical
SPH Zhongxi Pharmaceutical
Guizhou Shengjitang Pharmaceutical
Chengdu Hengrui Pharmaceutical
Zhejiang Wansheng Pharmaceutical
Shenzhen Neptunus Pharmaceutical
Shanghai Kaibao Pharmaceutical
Hangzhou Conba Pharmaceutical
Glaxosmithkline Pharmaceuticals
Xian Taiji Pharmaceutical
Beijing Taiyang Pharmaceutical
Shandong Zibo Xinda Pharmaceutical
Segment by Type
Thiazolidinediones
Biguanides
Others
Hospital
Drugstore
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Insulin Sensitizers market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Insulin Sensitizers, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Insulin Sensitizers industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Insulin Sensitizers in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Insulin Sensitizers introduction, etc. Insulin Sensitizers Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Insulin Sensitizers market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Insulin Sensitizers report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Insulin Sensitizers market is projected to reach US$ 20930 million in 2029, increasing from US$ 14290 million in 2022, with the CAGR of 5.6% during the period of 2024 to 2029. Demand from Hospital and Drugstore are the major drivers for the industry.
According to the Global Use of Medicines 2024 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Insulin Sensitizers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Sanofi
Novo Nordisk
Lilly
MSD
Boehringer Ingelheim
Chipscreen Biosciences
Shandong Lukang Pharmaceutical
Zhejiang Hisun Pharmaceutical
SPH Zhongxi Pharmaceutical
Guizhou Shengjitang Pharmaceutical
Chengdu Hengrui Pharmaceutical
Zhejiang Wansheng Pharmaceutical
Shenzhen Neptunus Pharmaceutical
Shanghai Kaibao Pharmaceutical
Hangzhou Conba Pharmaceutical
Glaxosmithkline Pharmaceuticals
Xian Taiji Pharmaceutical
Beijing Taiyang Pharmaceutical
Shandong Zibo Xinda Pharmaceutical
Segment by Type
Thiazolidinediones
Biguanides
Others
Segment by Application
Hospital
Drugstore
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Insulin Sensitizers market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Insulin Sensitizers, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Insulin Sensitizers industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Insulin Sensitizers in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Insulin Sensitizers introduction, etc. Insulin Sensitizers Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Insulin Sensitizers market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.